Diagnostic and medical device firm RadiaDyne has secured a U.S. patent for the monitoring of skin radiation dose during radiation treatment.
The patent broadly covers devices applied to the skin that relate to RadiaDyne's OARtrac patient dose monitoring platform, according to the company.
